Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 7/1/21 → 1/29/27 |
Financiación
- Syneos Health LLC: 83.958,00 US$
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy
- Ahmed, Sadiq (PI)